Elfadil Abass

665 total citations
27 papers, 428 citations indexed

About

Elfadil Abass is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Elfadil Abass has authored 27 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 15 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Elfadil Abass's work include Research on Leishmaniasis Studies (21 papers), Trypanosoma species research and implications (14 papers) and RNA modifications and cancer (2 papers). Elfadil Abass is often cited by papers focused on Research on Leishmaniasis Studies (21 papers), Trypanosoma species research and implications (14 papers) and RNA modifications and cancer (2 papers). Elfadil Abass collaborates with scholars based in Saudi Arabia, Sudan and Brazil. Elfadil Abass's co-authors include Michael Lohoff, Abdallah el Harith, Ulrich Steinhoff, Bärbel Camara, Nadine Bollig, Saul J. Semião-Santos, Magdalena Huber, Alexander Visekruna, Katharina Reinhard and Tak W. Mak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and European Journal of Immunology.

In The Last Decade

Elfadil Abass

25 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elfadil Abass Saudi Arabia 11 239 184 161 43 32 27 428
Camila Farias Amorim Brazil 11 183 0.8× 94 0.5× 116 0.7× 51 1.2× 10 0.3× 23 327
Jarbas E. Cardoso Brazil 8 229 1.0× 257 1.4× 152 0.9× 99 2.3× 8 0.3× 13 418
Chizu Sanjoba Japan 11 235 1.0× 130 0.7× 63 0.4× 63 1.5× 7 0.2× 41 316
Dana C. Gilmore United States 8 281 1.2× 121 0.7× 250 1.6× 69 1.6× 26 0.8× 9 469
Nelson D. Glennie United States 5 197 0.8× 132 0.7× 221 1.4× 51 1.2× 16 0.5× 8 393
Patrick T. Bunn Australia 9 240 1.0× 107 0.6× 210 1.3× 57 1.3× 8 0.3× 10 360
Isabel Monroy Spain 6 201 0.8× 126 0.7× 57 0.4× 61 1.4× 12 0.4× 12 250
Sara Montserrat‐Sangrà Spain 11 283 1.2× 154 0.8× 50 0.3× 138 3.2× 31 1.0× 16 376
Nicole Bertschi Switzerland 6 173 0.7× 44 0.2× 149 0.9× 31 0.7× 13 0.4× 12 311
Tânia Mara Pinto Dabés Guimarães Brazil 10 84 0.4× 129 0.7× 123 0.8× 27 0.6× 19 0.6× 25 312

Countries citing papers authored by Elfadil Abass

Since Specialization
Citations

This map shows the geographic impact of Elfadil Abass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elfadil Abass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elfadil Abass more than expected).

Fields of papers citing papers by Elfadil Abass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elfadil Abass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elfadil Abass. The network helps show where Elfadil Abass may publish in the future.

Co-authorship network of co-authors of Elfadil Abass

This figure shows the co-authorship network connecting the top 25 collaborators of Elfadil Abass. A scholar is included among the top collaborators of Elfadil Abass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elfadil Abass. Elfadil Abass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abass, Elfadil, et al.. (2025). Diagnostic performance of a novel point-of-care test for the diagnosis of visceral leishmaniasis in Sudan: A Comparative Accuracy Study. PLoS neglected tropical diseases. 19(4). e0012905–e0012905.
3.
Martinković, Franjo, Hosam Shams-Eldin, Alexandre Barbosa Reis, et al.. (2024). Comparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil. Pathogens. 13(2). 109–109. 2 indexed citations
4.
Alzahrani, Faisal A., et al.. (2021). Genetic Variants of RPL5 and RPL9 Genes among Saudi Patients Diagnosed with Thrombosis. Medical Archives. 75(3). 189–189. 1 indexed citations
5.
Albuali, Waleed H., et al.. (2021). Identification of RPL5 gene variants and the risk of hepatic vein thrombosis in Saudi patients. Saudi Medical Journal. 42(9). 969–974. 1 indexed citations
6.
Albuali, Waleed H., et al.. (2021). Genetic Variants of RPL5 and RPL9 Genes among Saudi Patients Diagnosed with Thrombosis.. PubMed. 75(3). 188–193. 2 indexed citations
7.
Abass, Elfadil, et al.. (2020). Leishmaniasis in Saudi Arabia: Current situation and future perspectives. Pakistan Journal of Medical Sciences. 36(4). 836–842. 10 indexed citations
8.
Abass, Elfadil, et al.. (2020). Performance of recombinant proteins in diagnosis and differentiation of canine visceral leishmaniasis infected and vaccinated dogs. European Journal of Microbiology and Immunology. 10(3). 165–171. 10 indexed citations
9.
Abass, Elfadil. (2020). Leishmania donovani infection in Eastern Sudan: Comparing direct agglutination and rK39 rapid test for diagnosis-a retrospective study. Asian Pacific Journal of Tropical Medicine. 13(7). 322–322. 2 indexed citations
10.
Abass, Elfadil, et al.. (2019). Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem. Pakistan Journal of Medical Sciences. 35(4). 1104–1109. 10 indexed citations
11.
Harith, Abdallah el, et al.. (2019). Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?. Open Forum Infectious Diseases. 6(10). ofz226–ofz226. 4 indexed citations
12.
Abass, Elfadil, et al.. (2017). Identification of an area predominantly endemic for childhood and adolescent visceral leishmaniasis in central Sudan. Acta Tropica. 178. 142–147. 12 indexed citations
13.
Alves, Márcio José Martins, et al.. (2016). Diagnostic accuracy of rKLO8 versus rK26 ELISAs for screening of canine visceral leishmaniasis. Acta Tropica. 166. 133–138. 14 indexed citations
14.
Abass, Elfadil, et al.. (2016). Local Production of a Liquid Direct Agglutination Test as a Sustainable Measure for Control of Visceral Leishmaniasis in Sudan. American Journal of Tropical Medicine and Hygiene. 94(5). 982–986. 11 indexed citations
15.
Abass, Elfadil, Franjo Martinković, Saul J. Semião-Santos, et al.. (2015). Heterogeneity of Leishmania donovani Parasites Complicates Diagnosis of Visceral Leishmaniasis: Comparison of Different Serological Tests in Three Endemic Regions. PLoS ONE. 10(3). e0116408–e0116408. 54 indexed citations
16.
Abass, Elfadil, Nadine Bollig, Katharina Reinhard, et al.. (2013). rKLO8, a Novel Leishmania donovani – Derived Recombinant Immunodominant Protein for Sensitive Detection of Visceral Leishmaniasis in Sudan. PLoS neglected tropical diseases. 7(7). e2322–e2322. 50 indexed citations
17.
Abass, Elfadil, et al.. (2011). Validation of a β-ME ELISA for detection of anti Leishmania donovani antibodies in Eastern Sudan.. PubMed. 8(3). 150–8. 12 indexed citations
18.
Reinhard, Katharina, Magdalena Huber, Elfadil Abass, et al.. (2011). c‐Rel promotes type 1 and type 17 immune responses during Leishmania major infection. European Journal of Immunology. 41(5). 1388–1398. 20 indexed citations
20.
Abass, Elfadil, et al.. (2006). β-Mercaptoethanol-modified ELISA for diagnosis of visceral leishmaniasis. Journal of Medical Microbiology. 55(9). 1193–1196. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026